SCHEMBL14645643

SCHEMBL14645643

CC(=O)Nc1ccc(CCCO)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 2/20 0.54
POLB P06746 1/20 0.54
AOC3 Q16853 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
HTT P42858 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TSHR P16473 2/20 0.53
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
CA12 O43570 1/20 0.52
BRD4 O60885 1/20 0.52
NR1I2 O75469 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
MB P02144 1/20 0.52
CYP1A1 P04798 1/20 0.52
CA3 P07451 1/20 0.52
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534832 0.95 CYP4F2 (0.56) CYP4A11POLBAOC3SMN1; SMN2HTT
SCHEMBL1902060 0.90 SMN1; SMN2 (0.59) POLBAOC3SMN1; SMN2HTTL3MBTL1
SCHEMBL11116153 0.90 SMN1; SMN2 (0.59) POLBAOC3SMN1; SMN2HTTL3MBTL1
SCHEMBL6629816 0.89 SMN1; SMN2 (0.57) CYP4A11POLBAOC3SMN1; SMN2HTT
SCHEMBL29622963 0.86 AOC3 (0.67) POLBAOC3SMN1; SMN2HTTL3MBTL1
SCHEMBL29622962 0.86 AOC3 (0.67) POLBAOC3SMN1; SMN2HTTL3MBTL1
SCHEMBL8868366 0.85 POLB (0.54) POLBAOC3SMN1; SMN2HTTL3MBTL1
SCHEMBL2748237 0.85 POLB (0.73) POLBSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL22873928 0.84 GAA (0.57) POLBSMN1; SMN2TSHRALDH1A1MEN1
SCHEMBL6949368 0.84 POLB (0.53) POLBAOC3SMN1; SMN2HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114058655-A Method for synthesizing (R) -acetamidophenylpropanol by enzyme-chemical one-pot method 青岛科技大学 2022-02-18 CN claimed
CN-114058655-A Method for synthesizing (R) -acetamidophenylpropanol by enzyme-chemical one-pot method 青岛科技大学 2022-02-18 CN disclosed
CN-114058655-A Method for synthesizing (R) -acetamidophenylpropanol by enzyme-chemical one-pot method 青岛科技大学 2022-02-18 CN disclosed
US-9321045-B2 Catalyst and process for synthesising the same THE UNIVERSITY OF WARWICK (GB) 2016-04-26 US disclosed
US-9321045-B2 Catalyst and process for synthesising the same THE UNIVERSITY OF WARWICK (GB) 2016-04-26 US disclosed
US-20150290634-A1 Catalyst and Process for Synthesising the Same THE UNIVERSITY OF WARWICK (GB) 2015-10-15 US disclosed
US-20150290634-A1 Catalyst and Process for Synthesising the Same THE UNIVERSITY OF WARWICK (GB) 2015-10-15 US disclosed
EP-2914609-A1 CATALYST AND PROCESS FOR SYNTHESISING THE SAME THE UNIVERSITY OF WARWICK (GB) 2015-09-09 EP disclosed
CN-104837854-A Catalyst and process for synthesising the same UNIV WARWICK 2015-08-12 CN disclosed
WO-2014068331-A1 CATALYST AND PROCESS FOR SYNTHESISING THE SAME THE UNIVERSITY OF WARWICK (GB) 2014-05-08 WO disclosed
WO-2013008256-A1 ONE POT ACYLATION OF AROMATIC AMINES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-01-17 WO disclosed
WO-2013008256-A1 ONE POT ACYLATION OF AROMATIC AMINES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2013-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150290634-A1 Catalyst and Process for Synthesising the Same CBR3, SPR, RNF5 CYP4A11 893/4885POLB 1627/4885AOC3 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.